Lexeo Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $19.50 on 07/11/24 and a low of $1.45 for the same time frame on 04/07/25.
52-week price history of LXEO Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Lexeo Therapeutics Inc’s current trading price is -80.10% away from its 52-week high, while its distance from the 52-week low is 167.59%. The stock’s price range during the 52-week period has remained between $1.45 and $19.50. In the Healthcare sector, the company’s shares saw a trading volume of around 1.93 million for the day, which was evidently higher than the average daily volume of 0.96 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Lexeo Therapeutics Inc (LXEO) has experienced a quarterly rise of 43.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 128.80M and boasts a workforce of 72 employees.
Making Sense of Trading Volume and Moving Average Data
Examining LXEO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LXEO stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.08.
LXEO Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -41.03% this year. Over the last six months, there has been a stronger performance of -47.21%. The price of LXEO fallen by 29.77% during the last 30 days period. For the last 5-days stocks have improved 42.65%.
